Psychopharmacology & The Human Aspect of LAIs

A single comment before surgery sticks for decades: “You must be pretty sick.” It was said after noticing an insulin pump, and it reveals a mistake we make all the time in mental health care. We treat certain treatment tools as proof of failure or severity, instead of seeing them as smart choices that can make day to day life easier. From that story, we step into the most misunderstood part of psychopharmacology: the adherence conversation. We talk about why missed doses are not automatically “resistance,” why forgetting is human, and why taking medication can feel like waking up to a diagnosis every morning. We also get practical about what helps: empathy before education, and motivational interviewing that starts with permission and curiosity. You’ll hear language you can use right away to explore ambivalence, uncover what an option represents to a patient, and move from persuasion to partnership. Then we dig into long acting injectables, including common fears about injections, the stigma attached to “shots,” and why LAIs can be less about control and more about freedom. We explore recovery-oriented care, the ripple effects on families who carry the reminder burden, and why offering evidence-based options earlier, including in first episode psychosis, may prevent relapse and protect a person’s life trajectory. If you care about medication adherence, shared decision-making, and reducing stigma in psychiatric treatment, this one will change how you frame choices. What treatment option might you be saving for later that deserves a place in today’s conversation?